BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 10531381)

  • 1. Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7.
    Yokouchi M; Kondo T; Houghton A; Bartkiewicz M; Horne WC; Zhang H; Yoshimura A; Baron R
    J Biol Chem; 1999 Oct; 274(44):31707-12. PubMed ID: 10531381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor.
    Lill NL; Douillard P; Awwad RA; Ota S; Lupher ML; Miyake S; Meissner-Lula N; Hsu VW; Band H
    J Biol Chem; 2000 Jan; 275(1):367-77. PubMed ID: 10617627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor receptor.
    Waterman H; Levkowitz G; Alroy I; Yarden Y
    J Biol Chem; 1999 Aug; 274(32):22151-4. PubMed ID: 10428778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sprouty fine-tunes EGF signaling through interlinked positive and negative feedback loops.
    Rubin C; Litvak V; Medvedovsky H; Zwang Y; Lev S; Yarden Y
    Curr Biol; 2003 Feb; 13(4):297-307. PubMed ID: 12593795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RING finger mutations that abolish c-Cbl-directed polyubiquitination and downregulation of the EGF receptor are insufficient for cell transformation.
    Thien CB; Walker F; Langdon WY
    Mol Cell; 2001 Feb; 7(2):355-65. PubMed ID: 11239464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors.
    Ettenberg SA; Rubinstein YR; Banerjee P; Nau MM; Keane MM; Lipkowitz S
    Mol Cell Biol Res Commun; 1999 Aug; 2(2):111-8. PubMed ID: 10542134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sprouty2 attenuates epidermal growth factor receptor ubiquitylation and endocytosis, and consequently enhances Ras/ERK signalling.
    Wong ES; Fong CW; Lim J; Yusoff P; Low BC; Langdon WY; Guy GR
    EMBO J; 2002 Sep; 21(18):4796-808. PubMed ID: 12234920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Terminally extended human ubiquitin-conjugating enzymes (E2s) mediate the ubiquitination of RING-finger proteins, ARA54 and RNF8.
    Ito K; Adachi S; Iwakami R; Yasuda H; Muto Y; Seki N; Okano Y
    Eur J Biochem; 2001 May; 268(9):2725-32. PubMed ID: 11322894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitination and proteasomal activity is required for transport of the EGF receptor to inner membranes of multivesicular bodies.
    Longva KE; Blystad FD; Stang E; Larsen AM; Johannessen LE; Madshus IH
    J Cell Biol; 2002 Mar; 156(5):843-54. PubMed ID: 11864992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between two ubiquitin-protein isopeptide ligases of different classes, CBLC and AIP4/ITCH.
    Courbard JR; Fiore F; Adélaïde J; Borg JP; Birnbaum D; Ollendorff V
    J Biol Chem; 2002 Nov; 277(47):45267-75. PubMed ID: 12226085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src-catalyzed phosphorylation of c-Cbl leads to the interdependent ubiquitination of both proteins.
    Yokouchi M; Kondo T; Sanjay A; Houghton A; Yoshimura A; Komiya S; Zhang H; Baron R
    J Biol Chem; 2001 Sep; 276(37):35185-93. PubMed ID: 11448952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.
    Joazeiro CA; Wing SS; Huang H; Leverson JD; Hunter T; Liu YC
    Science; 1999 Oct; 286(5438):309-12. PubMed ID: 10514377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitinylation and proteasome-dependent degradation of the phosphoinositide-specific phospholipase C gamma 1 in A-431 cells.
    Evdonin AL; Tsupkina NV; Nikol'skii NN; Medvedeva ND
    Dokl Biol Sci; 2003; 392():456-7. PubMed ID: 14650885
    [No Abstract]   [Full Text] [Related]  

  • 14. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
    Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
    J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficient to support receptor endocytosis.
    Huang F; Sorkin A
    Mol Biol Cell; 2005 Mar; 16(3):1268-81. PubMed ID: 15635092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cbl-mediated ubiquitination of alpha5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation.
    Kaabeche K; Guenou H; Bouvard D; Didelot N; Listrat A; Marie PJ
    J Cell Sci; 2005 Mar; 118(Pt 6):1223-32. PubMed ID: 15728256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment.
    de Melker AA; van der Horst G; Borst J
    J Biol Chem; 2004 Dec; 279(53):55465-73. PubMed ID: 15465819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
    Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
    J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination.
    Alwan HA; van Zoelen EJ; van Leeuwen JE
    J Biol Chem; 2003 Sep; 278(37):35781-90. PubMed ID: 12829707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1.
    Levkowitz G; Waterman H; Ettenberg SA; Katz M; Tsygankov AY; Alroy I; Lavi S; Iwai K; Reiss Y; Ciechanover A; Lipkowitz S; Yarden Y
    Mol Cell; 1999 Dec; 4(6):1029-40. PubMed ID: 10635327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.